Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group von Kröger, N M, Deeg, J H, Olavarria, E, Niederwieser, D, Bacigalupo, A, Barbui, T, Rambaldi, A, Mesa, R, Tefferi, A, Griesshammer, M, Gupta, V, Harrison, C, Alchalby, H, Vannucchi, A M, Cervantes, F, Robin, M, Ditschkowski, M, Fauble, V, McLornan, D, Ballen, K, Popat, U R, Passamonti, F, Rondelli, D, Barosi, G

Volltext

Melphalan 200 mg/m 2 in patients with renal impairment is associated with increased short-term toxicity but improved response and longer treatment-free survival von Sweiss, K, Patel, S, Culos, K, Oh, A, Rondelli, D, Patel, P

Volltext

A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis von Mascarenhas, J., Kosiorek, H., Prchal, J., Yacoub, A., Berenzon, D., Baer, M. R., Ritchie, E., Silver, R. T., Kessler, C., Winton, E., Finazzi, M. C., Rambaldi, A., Vannucchi, A. M., Leibowitz, D., Rondelli, D., Arcasoy, M. O., Catchatourian, R., Vadakara, J., Rosti, V., Hexner, E., Kremyanskaya, M., Sandy, L., Tripodi, J., Najfeld, V., Farnoud, N., Salama, M. E., Weinberg, R. S., Rampal, R., Goldberg, J. D., Mesa, R., Dueck, A. C., Hoffman, R.

Volltext

Decreased pulmonary function in asymptomatic long-term survivors after allogeneic hematopoietic stem cell transplant von Oh, A L, Patel, P, Sweiss, K, Chowdhery, R, Dudek, S, Rondelli, D

Volltext

Non-myeloablative allogeneic stem cell transplant with post-transplant cyclophosphamide cures the first adult patient with congenital dyserythropoietic anemia von Oh, A, Patel, P R, Aardsma, N, Mehendale, S R, Chowdhery, R, Sweiss, K, Rondelli, D

Volltext

First Blood & Marrow Transplant (BMT) Program in Nepal: a high cost procedure in a low economy country made available in a public hospital von Poudyal, B., Shah, B., Erickson, T., Rondelli, D.

Volltext

Prospective Assessment of Radiation Dose Toxicity Correlations in Patients Who Received Intensity Modulated Total Marrow Irradiation (IM-TMI) as Part of Conditioning Regimen Prior... von Bhave, S.R, Koshy, M, Akthar, A.S, Sengul, A, Weichselbaum, R.R, Patel, P, Rondelli, D, Aydogan, B

Volltext

CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia von Frangoul, Haydar, Altshuler, David, Cappellini, M. Domenica, Chen, Yi-Shan, Domm, Jennifer, Eustace, Brenda K, Foell, Juergen, de la Fuente, Josu, Grupp, Stephan, Handgretinger, Rupert, Ho, Tony W, Kattamis, Antonis, Kernytsky, Andrew, Lekstrom-Himes, Julie, Li, Amanda M, Locatelli, Franco, Mapara, Markus Y, de Montalembert, Mariane, Rondelli, Damiano, Sharma, Akshay, Sheth, Sujit, Soni, Sandeep, Steinberg, Martin H, Wall, Donna, Yen, Angela, Corbacioglu, Selim

Volltext

Can high volume leukapheresis substitute plerixafor to yield an optimal dose of CD34+ vells from poor mobilizers? von Lin, Y, Park, Y, Khanal, A, Patel, P, Campbell-Lee, S, Liu, L, Vidanovic, V, Sweiss, K, Peace, D, Rondelli, D, Mahmud, N

Volltext

Deferasirox increases BU blood concentrations von Sweiss, K, Patel, P, Rondelli, D

Volltext

Improvement in Health-related quality of life for Sickle Cell Disease Patients treated with Chemotherapy-Free Allogeneic Hematopoietic Stem-Cell Transplantation: a Pilot Study von Jalundhwala, Y.J, Saraf, S.L, Rondelli, D, Law, E.H, Pickard, A.S

Volltext

Allo-SCT for myelofibrosis: reversing the chronic phase in the JAK inhibitor era? von Tamari, R, Mughal, T I, Rondelli, D, Hasserjian, R, Gupta, V, Odenike, O, Fauble, V, Finazzi, G, Pane, F, Mascarenhas, J, Prchal, J, Giralt, S, Hoffman, R

Volltext

5612617 EFFICACY AND SAFETY OF A SINGLE DOSE OF EXAGAMGLOGENE AUTOTEMCEL FOR TRANSFUSION‐DEPENDENT‐THALASSEMIA AND SEVERE SICKLE CELL DISEASE von Fuente, J., Locatelli, F., Frangoul, H., Corbacioglu, S., Wall, D., Cappellini, M., Montalembert, M., Kattamis, A., Lobitz, S., Rondelli, D., Sheth, S., Steinberg, M., Walters, M., Bobruff, Y., Simard, C., Song, Y., Zhang, L., Sharma, A., Imren, S., Hobbs, B., Grupp, S.

Volltext

Selective apoptosis of monocytes and monocyte-derived DCs induced by bortezomib (Velcade) von Arpinati, M, Chirumbolo, G, Nicolini, B, Agostinelli, C, Rondelli, D

Volltext

Fludarabine i.v. BU conditioning regimen: myeloablative, reduced intensity or both? von Chunduri, S, Dobogai, L C, Peace, D, Saunthararajah, Y, Quigley, J, Chen, Y-H, Mahmud, N, Hurter, E, Beri, R, Rondelli, D

Volltext

Comorbidity index does not predict outcome in allogeneic myeloablative transplants conditioned with fludarabine i.v. busulfan (FluBu4) von Patel, P, Sweiss, K, Nimmagadda, S, Gao, W, Rondelli, D

Volltext

Reliability of a pretransplant i.v. BU test dose performed 2 weeks before myeloablative FluBu conditioning regimen von Beri, R, Chunduri, S, Sweiss, K, Peace, D J, Mactal-Haaf, C, Dobogai, L C, Shord, S, Quigley, J G, Chen, Y H, Mahmud, N, Rondelli, D

Volltext

CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis von RASPADORI, D, DAMIANI, D, LAURIA, F, LENOCI, M, RONDELLI, D, TESTONI, N, NARDI, G, SESTIGIANI, C, MARIOTTI, C, BIRTOLO, S, TOZZI, M

Volltext

Allostimulatory activity of CD133+ hematopoietic cells von Patel, P, Abbasian, J, Mahmud, D, Mahmud, N, Horsthemke, P M, Chunduri, S, Rondelli, D

Volltext

Plerixafor given before the third leukapheresis to rescue an unsuccessful stem cell mobilization with CY and G-CSF von Nimmagadda, S, Sweiss, K, Mahmud, N, Park, Y, Rondelli, D

Volltext